Meiact en es it fr

Category

Meiact
add to favotites goo dig stu tec squ mys
fac del pro twi yah mya far


Meiact Brand names, Meiact Analogs

Meiact Brand Names Mixture

  • No information avaliable

Meiact Chemical_Formula

C25H28N6O7S3

Meiact RX_link

http://www.rxlist.com/cgi/generic3/spectracef.htm

Meiact fda sheet

Meiact FDA

Meiact msds (material safety sheet)

Meiact Synthesis Reference

No information avaliable

Meiact Molecular Weight

620.724 g/mol

Meiact Melting Point

127 - 129 oC

Meiact H2O Solubility

Soluble at levels equal to < 0.1 mg/mL.

Meiact State

Solid

Meiact LogP

2.721

Meiact Dosage Forms

Tablets (200mg) for oral administration.

Meiact Indication

For the treatment of mild to moderate infections in adults and adolescents (12 years of age or older) which are caused by susceptible strains of microorganisms in acute bacterial exacerbation of chronic bronchitis, community-acquired pneumonia, pharyngitis/tonsillitis, and uncomplicated skin and skin-structure infections.

Meiact Pharmacology

Cefditoren pivoxil is a prodrug which is hydrolyzed by esterases during absorption, and the drug is distributed in the circulating blood as active cefditoren. Cefditoren is a cephalosporin with antibacterial activity against gram-positive and gram-negative pathogens. Cefditoren is effective against Staphylococcus aureus (methicillin-susceptible strains, including b-lactamase-producing strains), penicillin-susceptible strains of Staphylococcus aureus and Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae (including b-lactamase-producing strains), Haemophilus parainfluenzae (including b-lactamase-producing strains), Moraxella catarrhalis (including b-lactamase-producing strains), Streptococcus agalactiae, Streptococcus Groups C and G, and Streptococcus, viridans group (penicillin-susceptible and -intermediate strains).

Meiact Absorption

Following oral administration, cefditoren pivoxil is absorbed from the gastrointestinal tract and hydrolyzed to cefditoren by esterases. Under fasting conditions, the estimated absolute bioavailability of cefditoren pivoxil is approximately 14%. The absolute bioavailability of cefditoren pivoxil administered with a low fat meal (693 cal, 14 g fat, 122 g carb, 23 g protein) is 16.1 ± 3.0%.

Meiact side effects and Toxicity

Information on cefditoren pivoxil overdosage in humans is not available. However, with other b-lactam antibiotics, adverse effects following overdosage have included nausea, vomiting, epigastric distress, diarrhea, and convulsions. In acute animal toxicity studies, cefditoren pivoxil when tested at the limit oral doses of 5100 mg/kg in rats and up to 2000 mg/kg in dogs did not exhibit any health effects of concern.

Meiact Patient Information

No information avaliable

Meiact Organisms Affected

Enteric bacteria and other eubacteria